Centrosome amplification, which is a characteristic of cancer cells, has been understood as a driving force of genetic instability in the development of cancer. In previous work, we demonstrated that TEIF (transcriptional element-interacting factor) distributes in the centrosomes and regulates centrosome status under both physiologic and pathologic conditions. Here we identify TEIF as a downstream effector in EGF/PI3K/Akt signaling. The addition of EGF or transfection of active Akt stimulates centrosome TEIF distribution, resulting in an increase of centrosome splitting and amplification, while inhibitors of either PI3K or Akt attenuate these changes in TEIF and the associated centrosome status. A consensus motif for Akt phosphorylation (RHRVLT) proved to be involved in centrosomal TEIF localization, and the 469-threonine of this motif may be phosphorylated by Akt both in vitro and in vivo. Elimination of this phosphorylated site on TEIF caused reduced centrosome distribution and centrosome splitting or amplification. Moreover, TEIF closely co-localized with C-NAP1 at the proximal ends of centrioles, and centriolar loading of TEIF stimulated by EGF/Akt could displace C-NAP1, resulting in centrosome splitting. These findings reveal linkage of the EGF/PI3K/Akt signaling pathway to regulation of centrosome status which may act as an oncogenic pathway and induce genetic instability in carcinogenesis.
Introduction
The centrosome is composed of a pair of centrioles and pericentriolar matrix (PCM), and serves as the main cellular microtubule organizing center (MTOC). Centrosomes play a crucial role in the equal partition of chromosomes during cell mitosis, and they therefore must be precisely regulated to maintain accuracy of their function and maintain correct numbers of chromosomes within the cell. Centrosome amplification, which is defined as more than two centrosomes in one cell or by centrosome hypertrophy and/or fragmentation, is characteristic of many human cancers [1] [2] [3] [4] . Centrosome amplification is considered to be the driving force of genetic instability, as the multipolar spindles which result from centrosome amplification give rise to more than two daughter cells and cause genetic imbalance [5, 6] . Recent research reveals that extra centrosomes may induce merotelic attachment of the kinetochore allowing cells to bypass control by SAC (spindle assembly checkpoint) activity resulting in aneuploidy, which is a characteristic cancer cell phenotype [7, 8] . Mechanisms related to centrosome abnormalities in cancer have therefore been extensively explored, and many aspects of these mechanisms have been defined [9, 10] . Supernumerary centrosomes can simply arise from incomplete cell division and cell fusion, but are more frequently induced by the intrinsic regulating mechanism of centrosomal activity [11, 12] . Overexpression of matrix proteins, such as centrin, pericentrin and TACCS (transforming acidic coiled-coil containing proteins) has been credited with contributing to centrosomal abnormalities in tumorigenesis [4, 5, 11, 12] . However, the most important aspects of centrosomal abnormality involve the regulatory machinery which couples the cell cycle with centrosome activity, which results from the function of many kinds of genes and proteins. For example, inactivation of checkpoint genes, such as ATM, p53 and BRCA1 [12] [13] [14] , and over-expression of Aurora-A or B have been shown to result in centrosome dysfunction [15] [16] [17] . At the same time, in order to maintain a precise number of centrosomes, their duplication is tightly controlled by coordination of centrosomal proteins including a series of kinases PLK4 and Aurora-A together with proteasome activity. This allows proper assembly of procentriolar materials, and dysfunction of these molecules may cause overduplication of centrosomes [18] . In addition, duplicated centrosomes are connected through a linker and maintain a status of cohesion until centrosome separation occurs at the onset of mitosis. The disruption of cohesion in interphase may induce premature separation of centrosomes (centrosome splitting), and split centrosome may consequently be prone to recruit procentriolar materials and form additional centrioles [19, 20] . More importantly, emphasis has recently been laid on the relationship of oncogenic mutation and centrosome amplification, since oncogenic activation usually occurs in the early phase of carcinogenesis in most human cancers [21, 22] . K-ras mutation is in fact able to induce centrosome amplification and abnormal cell division through cyclin D1/CDK4 and Nek2a kinase [21] , while mutation of growth factor receptor met and the tumor promoter 12-0-tetradecanoylphorbol 13-acetate (TPA) have also been shown to be inducers of centrosome amplification [22, 23] .
EGF/PI3K/Akt is a major oncogenic signaling pathway which is activated by genomic mutations of EGFR, PI3KCA, PTEN or Akt, and this pathway is the most frequently detected promoting cancer cell growth, progression and metastasis in human cancer [24, 25] . This pathway has become one of the most important targets for tumor therapy [26] [27] [28] [29] . Mutation or over-expression of EGFRvIII induces centrosome amplification and chromosomal aberration, which can be synergistically enforced by simultaneous PTEN loss in glial tumors [30, 31] . In addition, activation of Aurora-A kinase by Akt has proved to induce centrosome amplification and consequent chromosome abnormality in cancer cells [32, 33] . However, the mechanism by which EGF/PI3K/Akt signaling and centrosome activity are coupled is far from clear, despite a discovery in the 1980s which revealed that the addition of EGF enhances the separation of centrosomes [34, 35] . To date, there have been several studies regarding EGF/PI3K/Akt signaling and its relation to centrosome activity and abnormalities. It has been shown that Akt1 is necessary for centrosome migration and spindle orientation in the early Drosophila melanogaster embryo, which acts through GSK-3 (glycogen synthase kinase-3) [36] . The Akt1-interactive factor Aki1 (Akt kinase-interacting protein 1) localizes in the centrosome and regulates centrosome cohesion [37] . In particular, it has further been shown that EGF can induce premature centrosome separation in the early S phase and consequently promote cell proliferation and survival [38] . In a recent study we have also demonstrated that Akt regulates distribution of the cytoskeleton modulator Girdin in the centrosome and midbody for participation in cell division [39] . Nevertheless, a more detailed investigation of regulation of the centrosome by EGF/PI3K/Akt signaling is warranted.
TEIF (transcriptional element-interacting factor) is a factor involved in the regulation of telomerase for promotion of cell proliferation [40, 41] . In a previous study, we showed that a portion of TEIF distributes at the centrosome and regulates its status under both physiological conditions and carcinogenesis, but the molecular details of this process remain to be worked out [42] . Careful analysis of the structure of TEIF showed that it seems to lack kinase activity despite its kinase-like structure [40] , but putative phosphorylation sites for several kinases including Akt were found in bioinformatical analysis. In addition, expression of TEIF in the centrosome reaches a high level upon release from a double-thymidine block or by addition of serum after starvation (unpublished data). We therefore hypothesize that TEIF is a downstream effector of EGF/PI3K/Akt signaling which serves in the regulation of centrosome activity.
Material and methods

Cell culture
HeLa, MCF-7, U2OS and PC3M cells and a series of stably-transfected HeLa cell lines expressing various segments of GFP-TEIF were cultured in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% FBS at 37°C in a 5% CO 2 atmosphere. For EGF treatment, cells were serum starved for 16 h and were then stimulated with recombinant human EGF (Sigma-Aldrich, Saint Louis, MO, USA) at a final concentration of 100 ng/ml for a period of time as indicated. In some experiments designated concentrations of LY294002 (Merck KGaA, Darmstadt, Germany) and perifosine (Selleck Chemicals, Houston, TX, USA) were added to the cultured cells after treatment with EGF.
Antibodies
Rabbit polyclonal anti-TEIF was described previously [42] . Mouse monoclonal anti-γ-tubulin and anti-β-actin were purchased from Sigma-Aldrich. Anti-Akt rabbit polyclonal antibody, rabbit monoclonal anti-phospho-Akt Ser473 (pAkt), and anti-phospho-Akt substrate (pAkt-MOTIF) were obtained from Cell Signaling Technology (Danvers, MA, USA). Rabbit polyclonal anti-GFP was purchased from MBL International Corp. (Woburn, MA, USA) and mouse monoclonal anti-CerbB2 was from Dako (Glostrup, Denmark). Rabbit polyclonal antibody anti-C-NAP1 was from Proteintech (Chicago, IL, USA), and anti-ninein, anticenexin and anti-pericentrin were from Abcam (Cambridge, MA, USA).
Plasmid construction and transfection
Restriction enzyme fragments encoding various portions of TEIF (Fig. 1A) were fused into pEGFP-C3 vectors (BD Biosciences Clontech, Franklin Lakes, NJ, USA), and centrin2 was fused into pEGFP-C3 and pDsRed2-C1 vectors (BD Biosciences Clontech, Franklin Lakes, NJ, USA), generating in-frame constructs expressing fusion proteins. Histagged full length TEIF (pcDHis-TEIF) was constructed as described previously [42] . Transient transfection was carried out using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's recommendations. For generating stable cell lines, cells were cultured in medium containing 800 μg/ml G418 (Sigma-Aldrich) and single clones were isolated and expanded.
Immunofluorescent microscopy
Cells grown on cover slides were fixed with ice-cold methanol for 5 min, blocked with horse serum for 60 min, and then incubated with anti-TEIF (1:300) and anti-γ-tubulin (1:500), C-NAP1 (1:100), ninein (1:100), cenexin (1:100), or pericentrin (1:1000) at 4°C overnight. The slides were washed and further treated with FITC or TRITC- conjugated antibodies (Sigma-Aldrich) at room temperature for 45 min and nuclear counterstained with 1 μg/ml DAPI (Sigma-Aldrich). Superresolution images of organelle structure were captured by a SIM (Structured Illumination Microscope) (Nikon SIM Ti-E, Japan) and images were processed using image processing software (NIS-Elements, Nikon, Japan). Both centrosome amplification and centrosome splitting were defined according to γ-tubulin staining, and γ-tubulin signals in 1000 counted cells, and ≥3 dots of γ-tubulin signal per cell was taken as centrosome amplification [11] . Centrosome splitting was recorded when the distance between two γ-tubulin-stained centrosomes was larger than 2 μm [43] . The rate of centrosome splitting or amplification (%) in stable HeLa-GFP-TEIF cells was calculated as [cells with centrosome splitting or amplification / cells with GFP-TEIF staining].
Immunoelectron microscopy
HeLa cells were fixed with 0.1 M sodium phosphate buffer (4% paraformaldehyde, and 0.1% glutaraldehyde) at 4°C overnight. The samples were embedded with Lowicryl K4M (BioChemika) and sections were prepared with the LEICA EM UC7 ultramicrotome. The sections were incubated with rabbit anti-TEIF antibody (1:100) in TBS (pH 7.4) containing 1% BSA and were further incubated with a mixture of 1:40-diluted gold particle (10 nm)-conjugated goat anti-rabbit IgG (Sigma-Aldrich) in TBS (pH 8.2) containing 2% BSA at r.t. for 2 h. Sections were then stained with saturated uranyl acetate. All sections were observed under a transmission electron microscope (JEOL-1230, Japan).
Immunoprecipitation and Western blotting
Cells were suspended in RIPA buffer (50 mM Tris-HCl [pH 7.2], 250 mM NaCl, 0.1% Triton-100, 2 mM EDTA, PMSF, and phosphatase inhibitor cocktail) for 5 min on ice. Cell extracts were pre-cleared by centrifugation at 12,000 rpm for 10 min at 4°C, and the supernatant was shaken with agarose conjugated with anti-GFP (monoclonal antibody, MBL International Corp.) at 4°C for 2 h. After flash centrifugation the precipitates were washed with RIPA buffer five times for 30 min and subjected to Western blotting.
Lysates or immunoprecipitation supernatant was resolved on 10% acrylamide gels by SDS-PAGE and transferred electrically to a PVDF membrane (Bio-Rad, CA, USA) at 25 V for 90 min. The blots were blocked in TBST buffer (10 mM Tris-HCl [pH 7.5], 150 mM NaCl, 0.1% Tween-20) containing 5% (w/v) nonfat dry milk for 60 min and then incubated with specific primary antibodies diluted in TBST buffer at 4°C overnight. Membranes were washed three times in TBST and incubated with horseradish peroxidase-conjugated secondary antibody for 1 h at room temperature. Membranes were washed five times and developed using the ChemiDoc XRS system (Bio-Rad).
In vitro kinase assay
Stably transfected HeLa-GFP-TEIF-ΔFX and HeLa-GFP-TEIF-ΔEF cells were serum starved for an additional 16 h before harvesting. GFP-TEIFs were immunoprecipitated from cell extracts and incubated with 200 ng recombinant Akt1 (Cell Signaling Technology) in the presence of 250 mM cold ATP in kinase buffer (Cell Signaling Technology) for 1 h at 30°C. The kinase reaction was stopped by the addition of loading buffer, and the samples were run on 10% SDS-PAGE gel and analyzed by Western blotting.
In vitro site-directed mutagenesis
According to the Lightning Site-Directed Mutagenesis method, we constructed two new mutants. The mutants were derived from a constructed plasmid, pEGFP-C3-TEIF-ΔEX, which at the same time served as the template for polymerase chain reaction (PCR). The mutagenic oligonucleotide primers (PCR primers) were as follows: ① T469A: upstream primer 5′-GACA CAGGGTCCTTgCCTCTGCCTTCAGC-3′ and downstream primer 5′-GCTGAAGGCAGAGGc AAGGACCCTGTGTC-3′; ② T469S: upstream primer 5′-GACACAGGGTCCTTtCCTCTGC CTTCAGC-3′ and downstream primer 5′-GCTGAAGGCAGAGGaAAGGACCCTGTGTC-3′. The lower case letters mark the nucleotide changes. Mutagenesis procedures were completed in a PCR thermal cycler. PCR reaction was carried out according to the manufacturer's protocol using the following PCR conditions: 95°C for 20 s, 60°C for 10 s; 72°C extension by TransStart FastPfu DNA polymerase for 7 min, followed by 17 cycles. The PCR products were then digested by a restriction enzyme-DpnI to remove the parental DNA (the templates). The resultant plasmids were confirmed by sequencing and designated as pGFP-TEIF-ΔEXT469A and pGFP-TEIF-ΔEXT469S.
Statistical analysis
All data were analyzed with SPSS statistics software (Version 13.0, Chicago, IL, USA). Relationships between tumor markers and other parameters were studied using the χ 2 -test and Pearson Chi-square, Continuity Correlation, and Fisher's extract tests. A p-value of less than 0.05 was considered to be statistically significant.
Results
Increasing centrosome targeting by TEIF induced centrosome splitting and amplification
Our previous study showed that TEIF localizes in the centrosome in interphase or mitosis via its C-terminal sequences [42] . Of even greater interest, centrosome splitting and amplification in the stablytransfected cell lines HeLa-GFP-TEIF-ΔEX and HeLa-GFP-TEIF-ΔHX ( Fig. 1A) were much more obvious than those in HeLa and HeLa-GFP-C3 cells, and were especially prominent in the cell line HeLa-GFP-TEIF-ΔHX (Fig. 1B) . As shown in Table 1 , taking the percentage of centrosome splitting and amplification in HeLa cells as the standard (15% and 2%, respectively), the four lines above all showed higher rates of splitting and amplification, while the rates in HeLa-GFP-TEIF-ΔEF, HeLa-GFP-TEIF-ΔEB and HeLa-GFP-C3 were no higher than the HeLa cell standard.
To confirm the effect of TEIF on centrosome status, ectopic fulllength TEIF was introduced into several cell lines, including HeLa, MCF-7, PC3M and U2OS, and their centrosomes were analyzed by staining with γ-tubulin. The results showed that over-expression increased centrosome splitting and amplification of HeLa and MCF-7 (Fig. 1C , upper and lower panels) or PC3M and U2OS cells (data not shown).
These data suggested that increasing centrosome targeting of TEIF alters centrosome status.
EGF/PI3K signaling stimulates TEIF centrosome targeting
The fact that increasing centrosome targeting of TEIF can alter centrosome status prompted us to explore the signaling cascade which regulates TEIF centrosome localization. Bioinformatical analysis on the website http://scansite.mit.edu revealed one consensus motif for Akt phosphorylation "RHRVLT" at amino acids 464-469 in TEIF (Fig. 1A) [44, 45] . It is noteworthy that this motif was covered in the constructs which showed capacity for centrosome localization such as TEIF-ΔEX, -ΔHX, -ΔFX and -ΔFP-1, but was not present in the vehicles -ΔEF and -ΔEB which showed no TEIF centrosome distribution. The consensus motif of TEIF (RHRVLT) indicated that EGF/PI3K/ Akt might be involved in TEIF associated centrosome activity. To test this, HeLa cells or stably-transfected GFP-TEIF-ΔHX (this N-terminal deleted construct was used in some experiments because it presented more clear centrosome localization with lower background, but has effects on centrosome similar to those of full-length TEIF shown in the experiments above), was treated with EGF and the expression of endogenous and exogenous TEIF and centrosome status were analyzed. Under EGF treatment (100 ng/ml, 8 h), HeLa ( Fig. 2A) and HeLa-GFP-TEIF-ΔHX cells (Fig. 2B) showed elevated centrosomal expression of TEIF and an increase in the positive rates of centrosome splitting and amplification ( Fig. 2A, B) . The addition of EGF at the same dosage increased centrosome splitting in HeLa cells from 10% to 32% and increased amplification from 1.5 to 6% (Fig. 2C) . In HeLa-GFP-TEIF-ΔHX cells, the EGF-treated HeLa-GFP-TEIF-ΔHX cells showed an increase in centrosome splitting from 25% to 38%, while the rate of amplification increased from 5% to 8%, in comparison with untreated HeLa-GFP-TEIF-ΔHX cells. Apparently the differences between the original HeLa cells and the HeLa-GFP-TEIF-ΔHX cells in centrosome splitting and amplification are caused by increased expression of TEIF in the centrosome. In addition, the effects of EGF on TEIF and its associated centrosome activity were verified with LY294002, a special inhibitor of PI3K which is the key mediator in the downstream of EGF that triggers signaling and activates Akt by phosphorylation. Notably, treatment of cells with LY294002 (10 μM) markedly attenuated EGF-induction of TEIF and decreased centrosome amplification and splitting ( Fig. 2A, B, C) .
To clarify whether treatment with EGF enhances the total level of TEIF expression, Western Blotting analysis was performed. As expected, the addition of EGF markedly stimulated pAkt, but did not alter the total expression of either endogenous or exogenous TEIF expression as shown in Fig. 2D . Similarly, LY294002 reduced the level of pAkt but had no effect on TEIF (Fig. 2D ). It appears that EGF affects mainly the distribution of TEIF but not its expression.
Taken together, these results confirmed that EGF/PI3K can stimulate the centrosomal distribution of TEIF and alter the associated centrosome status.
Akt activity increases centrosome targeting of TEIF
Akt is the primary mediator in EGF/PI3K signaling, and our analysis revealed that there is an Akt motif in TEIF. It was therefore reasonable to suggest that EGF/PI3K regulates TEIF and its associated centrosome status through Akt. To evaluate this, three plasmids Akt1-WT (wild type Akt1), Akt1-DA (dominant active, myristylated Akt1 lacking the pleckstrin homology domain, residues 4-125) and Akt1-DN (dominant negative Akt1, Akt1-MAA: K179M/T308A/S473A) were used. After transient transfection into HeLa-GFP-TEIF-ΔEX cells, GFP-TEIF and the centrosomes in cells with Akt1-WT, Akt1-DA or Akt1-DN were analyzed. The Akt1-DA group showed much more intense distribution of GFP-TEIF over the centrosomes, together with increased centrosome splitting and amplification as compared to Akt1-WT or Akt1-DN (Fig. 3A) . The rates of centrosome splitting or amplification in the Akt1-DA group were much higher than those of other groups, especially the Akt1-DN group (Fig. 3B) . However, transfection of Akt1-WT, Akt1-DA, or Akt1-DN did not change the level of TEIF as analyzed by Western blotting (Fig. 3C) , although pAkt expression was stimulated remarkably in both Akt1-WT and Akt1-DA (Fig. 3C) . These results indicated that activated Akt stimulates centrosome splitting or amplification mainly through TEIF centrosome localization but not by up-regulation of TEIF global expression.
Perifosine, a new synthetic alkylphospholipid Akt inhibitor, inhibits Akt activation by targeting the pleckstrin homology domain of Akt [46, 47] . To further evaluate the role of Akt activity in TEIF regulation, a trial of perifosine as a dose-dependent inhibitor was carried out, in which HeLa cells were incubated with increasing concentrations of perifosine (0, 5 μM, 10 μM, 20 μM) for 12 h. As shown in Fig. 4A , perifosine reduced the level of pAkt in a dose-dependent manner, but showed no effect on total Akt protein or TEIF levels. At the same time, the rate of centrosome splitting or amplification gradually decreased with increasing concentrations of perifosine (Fig. 4B) . As expected, the centrosome distribution of TEIF was reduced in the presence of perifosine (Fig. 4C) . However, treatment with perifosine did not reduce centrosomal distribution of other centrosomal proteins, including centrin, γ-tubulin, pericentrin, ninein, and so on (data not shown). This suggested that pAkt regulation of TEIF centrosomal targeting is specific.
Akt1 directly phosphorylates TEIF both in vitro and in vivo
The results from our experiments strongly suggested that Akt plays an important role in regulation of TEIF. We therefore sought to determine whether TEIF is a specific substrate of Akt in vitro and in vivo.
Antibodies specific for a phosphorylated motif (i.e., phosphosubstrate antibodies) have been valuable in identifying new Akt substrates over the past five years [48] [49] [50] . These antibodies were raised against degenerate phospho-peptides containing the phosphorylated form of a small Akt substrate motif (RXRXXS/T) [51] . For in vivo assay, HeLa-GFP-TEIF-ΔFX (with the RHRVLT-motif) and HeLa-GFP-TEIF-ΔEF (without the RHRVLT-motif) were treated with EGF (100 ng/ml, 8 h), followed by immunoprecipitation. The precipitated GFP-TEIF-ΔFX and GFP-TEIF-ΔEF proteins were then immunoblotted with the pAkt-MOTIF antibody, and phosphorylation of the pAkt-MOTIF could be detected in HeLa-GFP-TEIF-ΔFX, but not in HeLa-GFP-TEIF-ΔEF (Fig. 5A) , indicating that pAkt could phosphorylate the consensus motif of TEIF in living cells.
The direct phosphorylation of TEIF by Akt was also confirmed by an in vitro Akt assay. GFP-TEIFs, GFP-TEIF-ΔFX or GFP-TEIF-ΔEF was directly To further evaluate Akt-mediated TEIF phosphorylation, out-or inphosphorylation was carried out by in vitro site-directed mutagenesis, in which the 469-threonine in the "RHRVLT" TEIF motif was mutated to alanine or serine. The mutant constructs pGFP-TEIF-ΔEXT469A and pGFP-TEIF-ΔEXT469S and wild-type pGFP-TEIF-ΔEX were stably transfected into HeLa cells and in vivo phosphorylation assays were performed in the presence of EGF (100 ng/ml, 8 h) as described above. The results showed that the phosphorylated TEIF in both pGFP-TEIF-ΔEXT469S and pGFP-TEIF-ΔEX could bind with the pAkt-MOTIF antibody under EGF stimulus, but no signal was found with the group pGFP-TEIF-ΔEXT469A (Fig. 5C ), although elevated pAkt was displayed in all lysates of these three transfectants. This showed that pAkt could phosphorylate the 469-threonine (or serine) in the consensus "RHRVLT" of TEIF.
These results together argue strongly that activated Akt can directly phosphorylate TEIF, which in turn suggests that TEIF may be a direct substrate of Akt1.
Abolition of the phosphorylation site results in decreased centrosome localization of TEIF and EGF response
To clarify the effects of Akt-mediated TEIF phosphorylation, the mutant constructs pGFP-TEIF-ΔEXT469A and pGFP-TEIF-ΔEXT469S and wild-type pGFP-TEIF-ΔEX were stably transfected into HeLa cells, and as expected, the mutation of the TEIF phosphorylation site markedly decreased centrosomal loading of TEIF, even in the presence of EGF (Fig. 6A) . GFP-TEIF-ΔEXT469A was observed in only a few cells (5%) while up to 60-70% cells were found in GFP-TEIF-ΔEXT469S and GFP-TEIF-ΔEX with centrosomal TEIF (Fig. 6B) . In addition, abolition of phosphorylation also caused a decrease in centrosome splitting in cells with pGFP-TEIF-ΔEXT469A, in comparison with those with pGFP-TEIF-ΔEXT469S and pGFP-TEIF-ΔEX (p b 0.05) (Fig. 6C) . Not unexpectedly, loss of the EGF response was also significant in pGFP-TEIF-ΔEXT469A transfected cells (p b 0.01) (Fig. 6C) . At the same time, centrosome amplification was slightly decreased in cells with GFP-TEIF-ΔEXT469A (p N 0.05) with EGF stimulus (Fig. 6D) . Nevertheless, there was still some response in cells with GFP-TEIF-ΔEXT469A, and this may reflect the effect of endogenous TEIF. Consequently, there was a significant difference (p b 0.05) in the formation of bi-or multi-nucleated cells owing to abnormal mitosis in GFP-TEIF-ΔEXT469A and GFP-TEIF-ΔEX or GFP-TEIF-ΔEXT469S in the presence of EGF (Fig. 6E ).
Sub-localization of TEIF in the centriole
Centrosome spitting is the loss of connection between paired centrioles. In order to gain insight into the mechanism of regulation of centrosome spitting by Akt-coupled TEIF, the sub-localization of TEIF in centrioles was investigated through analysis of TEIF with other centrosomal proteins which have distinct locations in the centrosome, including centrin2 (distal end of the centriole), pericentrin (pericentriolar matrix), cenexin (appendage), ninein (appendage), and C-NAP1 (proximal end of centriole). With co-transfection of GFP-TEIF-ΔHX and DsRed-centrin2, images revealed that GFP-TEIF-ΔHX did not completely overlap (Fig. 7A, upper panels) , and use of super-resolution microscopy showed that centrin2 separated from TEIF in either unduplicated ( Fig. 7A, lower panels, I ) or duplicated (Fig. 7A, lower panels, II) centrioles. In contrast, TEIF showed nearly complete co-localization with C-NAP1 (Fig. 7B, upper panels) . Super-resolution imaging confirmed this co-localization of C-NAP1 with TEIF in pre-duplicated centrioles (Fig. 7B, lower panels, I ), and also more clearly showed that C-NAP1 in duplicated centrioles still largely overlapped with TEIF and was more closely located between two centrioles (Fig. 7B, lower panels,  II) . As centrin2 and C-NAP1 localize in the distal ends and proximal ends of centrioles respectively, based on the above results TEIF should localize in the proximal ends of centrioles. To confirm this, immuno-electron microscopy was performed which demonstrated that TEIF mainly localized in the proximal ends of centrioles (Fig. 7C) . The relative location of centrin2, TEIF and C-NAP1 is summarized and depicted in a sketch (Fig. 7D) .
Increased centrosome targeting of TEIF alters the distribution of C-NAP1
C-NAP1 which is located in the proximal ends of the centriole is an important factor for maintaining cohesion of centrioles in interphase [43] . Upon phosphorylation of C-NAP1 by Nek2 which occurs in the late G2 phase, C-NAP1 departs from the proximal centriole ends and triggers the separation of paired centrioles. Abnormal C-NAP1 can result in centriole splitting with premature separation of centrosomes [43] . Because TEIF localizes closely with C-NAP1, the effects of TEIF centrosome loading on C-NAP1 were explored. With over-expression of TEIF (GFP-TEIF-ΔHX), reduced C-NAP1 centrosomal localization was observed in GFP-TEIF-ΔHX transfected cells (Fig. 8A , cells with GFP) in comparison to untransfected cells (Fig. 8A, control panel, asterisks indicate cells). In the presence of EGF, cells with increased centrosomal TEIF (GFP-TEIF-ΔHX) showed reduced C-NAP1 (Fig. 8A, EGF panels) . And as expected, the untransfected cells with EGF-treatment (Fig. 8A , EGF panels, asterisks indicate cells) showed reduced C-NAP1 as compared to those of the control group (Fig. 8A , control panel, asterisks indicate cells). Similarly, in comparison with wild-type (GFP-TEIF-ΔEX) or GFP-TEIF-ΔEXT469S, cells with phosphorylation site-mutated GFP-TEIF-ΔEXT469A also presented about 1.5 fold increase of C-NAP1 in the centrosome (Fig. 8B) , implying that the decrease of centrosomal TEIF could increase C-NAP1.
These results indicate that increasing centrosome loading of TEIF could result in displacement of C-NAP1.
Discussion
Although activation of EGF/Akt is a frequently identified event in tumorigenesis, there have been few descriptions of its activity related to centrosome amplification. In the early 1980s, Sherline and Mascardo reported that the addition of EGF enhances the separation of centrosomes [34, 35] . However, it has been only recently that molecular evidence has emerged showing Akt together with other proteins is responsible for EGF/PI3K/Akt signaling which regulates centrosome activity [36] [37] [38] [39] . In particular, Mardin et al. recently showed that EGF can induce premature centrosome separation in the early S phase and consequently promote proliferation and survival of cells [38] . In a genetic model, Buttrick et al. discovered that Akt1 is necessary for centrosome migration and spindle orientation in the early D. melanogaster embryo by acting through GSK-3 (glycogen synthase kinase-3) [36] . In addition, activation of Aurora-A kinase by Akt has proved to induce centrosome amplification and consequent chromosome abnormality in cancer cells [32, 33] . Thus, the signaling pathway consisting of Akt kinase and its upstream or downstream regulators has come to be understood as an important part of the machinery for centrosome activity.
Coupled with cell cycle progression, one centrosome cycle undergoes sequential events including centriole disengagement, centriole duplication, centriole elongation, and centrosome separation and maturation, forming a twin apparatus for equal of partition of the cell's set of chromosomes [18, 52] . Prior to the onset of mitosis, duplicated centrosomes are believed to be connected through a linker. This cohesion may be important for protection of the centrosome from abnormal duplication and for maturation of daughter centrosomes, while disjunction of connected centrosomes is necessary for separation as well as migration in the late G2 phase [18, 19, 52] . Cohesion results from a proteinaceous linker which connects the proximal centrosome ends, and C-NAP1, rootletin and β-catenin localize and are believed to be involved in centrosome cohesion [19, 43] . In addition to C-NAP1 and rootletin, other centrosomal proteins such as Cep68 and Cep215 (CDK5RAP2) have also been identified as possible linker proteins [19] . Displacement of linker proteins is proposed to regulate cohesion status, where localization of linker proteins enhances cohesion while their displacement induces disjunction [43] . The distribution of linker proteins is determined by the balance between phosphorylation and dephosphorylation of Nek2a kinase and PP1γ phosphatases [43] . It has been established that Nek2 kinase and C-NAP1 are major regulators which trigger centrosome splitting or separation [43] . Recently it has been revealed that EGF can induce centrosome separation via stimulation of Nek2a activity [38] . Centrosome splitting is the premature separation of centrosomes in interphase, and splitting may therefore reflect a defect in centrosome cohesion or an unscheduled separation [19] . A link between centrosome splitting and amplification has in fact been documented, indicating that disruption of cohesion may cause premature centrosome splitting and consequently result in centrosome amplification. For example, β-catenin which is a key factor in Wnt-signaling is involved in centrosome cohesion. Inactivated β-catenin maintains a status of centrosome cohesion, but β-catenin is activated upon the decrease of GSK-3β kinase phosphorylation and induces centrosome splitting and amplification [53] . Overexpression of Sik2, a kinase which acts in the regulation of centrosome cohesion, may also induce centrosome splitting and amplification in ovarian cancers [54] . More convincingly, centrosome splitting has been considered a major step in DNA damage-induced centrosome amplification [55] . Nevertheless, it is unclear how loss of cohesion causes centrosome amplification. Some evidence shows that prematurely split centrosomes are prone to recruit procentriolar materials [18, 20] . In this study our findings suggest that TEIF localizes at the proximal ends of centrosomes close to C-NAP1, showing that TEIF may play a role in the regulation of centrosome cohesion, as increased centrosomal expression of TEIF induces centrosome splitting in addition to centrosome amplification. Moreover, these results also highlight a possible TEIF function by which Akt signaling is linked with centrosome cohesion, which consists of increased centrosomal targeting of TEIF stimulated by EGF or activated Akt induced centrosome splitting. Nevertheless, the more detailed investigation of the mechanism of regulation of centrosome activity by TEIF is warranted, and should include the evaluation of integration of TEIF with other centrosomal proteins, interaction between TEIF and C-NAP1, and so on. It is worth mentioning that Nakamura et al. described Aki1 (Akt kinase-interacting protein 1) which localizes at the centrosome and regulates centrosome cohesion, suggesting functional involvement of Akt in centrosome cohesion [37] . Thus, exploration of the interaction of TEIF and Nek2a or C-NAP1 may provide further evidence regarding the role TEIF plays in centrosome cohesion and/or separation.
In summary, the present investigation provides a bridge linking EGF/ PI3K/Akt signaling and centrosome status in tumorigenesis. Considering the prevalence of EGF/PI3K/Akt signaling in human cancers, it is reasonable to believe that the role of TEIF not only will open a new window for viewing the mechanism of oncogenic signaling in cancer development, but also will cast a new light on potential molecules for targeted therapy in human cancers.
